Clinical Trials Directory

Trials / Conditions / Primary Mediastinal (Thymic) Large B-Cell Lymphoma

Primary Mediastinal (Thymic) Large B-Cell Lymphoma

7 registered clinical trials studyying Primary Mediastinal (Thymic) Large B-Cell Lymphoma — 2 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationNivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma
NCT06871007
St. Petersburg State Pavlov Medical UniversityPhase 1 / Phase 2
RecruitingTesting Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lym
NCT05633615
SWOG Cancer Research NetworkPhase 2
Active Not RecruitingAcalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma
NCT04257578
University of WashingtonPhase 1 / Phase 2
SuspendedNivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma
NCT03704714
Northwestern UniversityPhase 1 / Phase 2
CompletedPembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin
NCT03210662
M.D. Anderson Cancer CenterPhase 2
UnknownStudy of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggres
NCT02747732
Meirav Kedmi MDPhase 2
CompletedDose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies
NCT01760226
Baylor College of MedicineEARLY_Phase 1